Category: Smith & NephewSyndicate content

COV shareholder sues to block pending MDT merger | Medtech legal news for the week of August 18, 2014

August 18, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Another Covidien shareholder sues to block Medtronic merger; Ex-Integra sales rep, manager cop to $800k hospital fraud scheme; Diabetes: Medtronic, Johnson & Johnson settle patent spat; Stryker settles hip implant suit against J&J's DePuy; Appeals court reverses Medtronic's win in Lenox bone mill spat

Another Covidien shareholder sues to block Medtronic merger

August 12, 2014 by Brad Perriello

Stryker settles hip implant suit against J&J's DePuy

August 13, 2014 by Brad Perriello

Stryker Corp. settles a patent infringement lawsuit filed against Johnson & Johnson's DePuy Orthopaedics division; co-defendants Wright Medical, Zimmer Holdings and Smith & Nephew move to have their cases tossed as well.

Stryker settles hip implant suit against J&J's DePuy

Analyst: Stryker may buy Smith & Nephew yet | MassDevice.com On Call

August 13, 2014 by Arezu Sarvestani

One analyst still sees potential for a Stryker merger with Smith & Nephew, even though S&N CEO Olivier Bohuon says he's not up for it.

MassDevice.com On Call

Lack of FDA approval is no longer a deal-breaker for a big exit | The week in medtech M&A

August 6, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Report: Medtech M&A exits don't hinge on FDA approval; White House rails against Medtronic-style corporate inversions; Smith & Nephew CEO: We've been an M&A target for 10 years; More mega-merger talk from medtech giants; Baxter sheds vaccines biz for $635M

Report: Medtech M&A exits don't hinge on FDA approval

July 31, 2014 by Arezu Sarvestani

Report: Medtech M&A no longer hinges on FDA approval

Smith & Nephew CEO: We've been an M&A target for 10 years

August 1, 2014 by Brad Perriello

Smith & Nephew CEO Olivier Bohuon says the company is under no pressure to be acquired after at least 10 years as a prominent M&A target.

YYmeta

Smith & Nephew (FTSE:SN, NYSE:SNN) isn't in a big rush to jump on the mega-merger bandwagon, CEO Olivier Bohuon said today.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Smith & Nephew aims to halve ortho device prices with 'no-frills' option

August 1, 2014 by Brad Perriello

Smith & Nephew's new, 'no-frills' Syncera program aims to cut orthopedic medical device prices in half for a slice of the U.S. hospital market.

Smith & Nephew aims to halve device prices with 'no-frills' option

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Smith & Nephew shifts jobs to China

July 31, 2014 by Arezu Sarvestani

Smith & Nephew confirms that it's cutting some of its U.K. manufacturing jobs and moving the positions to a plant in China.

Smith & Nephew shifts jobs to China

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp